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Regulation of the Human 
Phosphatase PTPN4 by the inter-
domain linker connecting the PDZ 
and the phosphatase domains
Célia Caillet-Saguy1, Angelo Toto2, Raphael Guerois3, Pierre Maisonneuve  1, Eva di Silvio2, 
Kristi Sawyer1, Stefano Gianni2 & Nicolas Wolff1
Human protein tyrosine phosphatase non-receptor type 4 (PTPN4) has been shown to prevent cell 
death. The active form of human PTPN4 consists of two globular domains, a PDZ (PSD-95/Dlg/ZO-1) 
domain and a phosphatase domain, tethered by a flexible linker. Targeting its PDZ domain abrogates 
this protection and triggers apoptosis. We previously demonstrated that the PDZ domain inhibits 
the phosphatase activity of PTPN4 and that the mere binding of a PDZ ligand is sufficient to release 
the catalytic inhibition. We demonstrate here that the linker connecting the PDZ domain and the 
phosphatase domain is involved in the regulation of the phosphatase activity in both PDZ-related 
inhibition and PDZ ligand-related activation events. We combined bioinformatics and kinetic studies to 
decipher the role of the linker in the PTPN4 activity. By comparing orthologous sequences, we identified 
a conserved patch of hydrophobic residues in the linker. We showed that mutations in this patch affect 
the regulation of the PTPN4 bidomain indicating that the PDZ-PDZ ligand regulation of PTPN4 is 
a linker-mediated mechanism. However, the mutations do not alter the binding of the PDZ ligand. 
This study strengthens the notion that inter-domain linker can be of functional importance in enzyme 
regulation of large multi-domain proteins.
Protein-tyrosine phosphatases (PTPs) represent the largest family of human phosphatases. These enzymes are 
critical in regulating signal transduction and their impairment has been previously associated with human dis-
eases1. PTPN4 is a non-receptor tyrosine phosphatase whose multiple functions have been linked to T-cell signal-
ling, learning, spatial memory and cerebellar synaptic plasticity2–4. Its overexpression reduces cell proliferation 
in COS-7 (CV-1 (simian) in Origin and carrying the SV40 genetic material) cells and suppresses CrkI-mediated 
cell growth and mobility in HEK293T (Human embryonic kidney) cells5, 6. Recently, PTPN4 has been identified 
as a specific inhibitor of the TIR-domain-containing adapter-inducing interferon-β-dependent toll-like receptor 
4 pathway7.
From a structural perspective, PTPN4 (UniProt P29074) is a large modular protein containing a N-terminal 
FERM (Band 4.1, Ezrin, Radixin, and Moesin) domain, a PDZ (PSD-95/Dlg/ZO-1) domain and a C-terminal 
catalytic tyrosine phosphatase domain (Fig. 1). PTPN4 is localized in the cytoplasm and at the plasma membrane. 
After suppression of the FERM domain, the phosphatase is exclusively cytoplasmic8. PTPN4 is proteolysed in the 
cell by calpain in response to physiological stimuli, leading to enzyme activation9. In vitro, PTPN4 is cleaved and 
activated by both trypsin and calpain9. The active form of PTPN4 consists of the PDZ and PTP domains (Fig. 1).
We previously showed that PTPN4 prevents the induction of cell death in glioblastoma cell lines in a 
PDZ-PDZ ligand (or PDZ binding motif called PBM) dependent manner10. Targeting PTPN4-PDZ domain was 
shown to abrogate this protection and to trigger apoptosis. We recently identified the mitogen-activated protein 
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kinase (MAPK) p38γ (also known as MAPK12) as a cellular partner of PTPN4. The PBM of p38γ has the highest 
affinity of all PBM from endogenous partners of PTPN4 and has a similar affinity to the optimized pro-death 
13-amino acids peptide Cyto8-RETEV. Both peptides are efficient inducers of cell death after their intracellular 
delivery11, 12. Furthermore, we showed that the PDZ domain of PTPN4 inhibits the phosphatase activity, while a 
PBM bound to the PDZ domain abrogates the auto-inhibition of the catalytic activity of PTPN411, 13.
While it is clear that the PDZ domain regulates the activity of PTPN4, the mechanism of crosstalk between the 
PDZ and PTP domains remains poorly understood and appears to be rather complex. In particular, previously 
published NMR (nuclear magnetic resonance) data indicated that the transition from the auto-inhibited state 
to the active state of PTPN4 is mediated by a modification of the global dynamic behaviour of the PDZ domain 
when going from the unbound to the bound state13. Of particular interest is the observation that, in order to 
communicate, the PDZ and PTP domains must be covalently linked as shown by the absence of inhibition when 
PTPN4-PDZ is added in trans to the linker-PTP construct13. These observations suggest that the linker has a 
crucial functional role in the communication between the two domains. Yet, the inter-domain linker of PTPN4 
is flexible and unstructured, and does not display any direct detectable interactions by NMR with either the PDZ 
or the PTP domains13.
In this study, we investigate the role of the disordered linker connecting the PDZ and PTP domains in the 
active PDZ-PTP bidomain construct of PTPN4 (Fig. 1). To that end, the mechanism of regulation of PTPN4 
activity was tackled both by bioinformatics and steady state kinetic experiments. We highlight a hydrophobic 
patch in the linker conserved among the PTPN4 orthologous sequences. Mutations in this conserved hydropho-
bic patch modify both the inhibition of the phosphatase activity of PTPN4 by the PDZ domain and the abrogation 
of the inhibition by the PBM binding. Our results shed light on the mechanism of PDZ-PBM mediated regulation 
of PTPN4 that is, at least in part, affected by the sequence of the linker.
Results
Structural and dynamics features of the linker. Bioinformatics analysis and structural features of the 
linker. PTPN4 PDZ-PTP active bidomain comprises two well-structured domains linked by an inter-domain 
sequence corresponding to residues 605 to 637 (Fig. 1). We previously stated that the linker was disordered by 
NMR but we also hypothesized that transient interactions operate in the bidomain. To access the structural fea-
tures of the linker, the sequence of the linker was analysed using a panel of protein sequence analysis programs 
accessible from the NPS (network protein sequence) website for secondary structure predictions (https://npsa-
prabi.ibcp.fr). Figure 2a shows the results obtained from different approaches – DSC14, MLRC15, PHD16 – and 
the consensus secondary structure prediction. Common features to all results are that a helix is predicted down-
stream of the PDZ domain (residues 605–614) and that the linker after residue 615 does not adopt any regular 
secondary structure. We have previously reported the resonance assignments of the linker (residue 605 to 637) 
for the PDZ-linker and the bidomain constructs (Fig. 1). Using the TALOS-N approach17 based on the resonance 
frequencies, the stretch of residues 605–614 is predicted as a β-strand with a low probability (<0.6) below the 
significant threshold (Fig. 2b). Thus, the linker is predominantly disordered in solution.
In addition, we used IUPred program from IUPred web server (http://iupred.enzim.hu)18 to determine the 
ordered or disordered characteristics of the linker in the PTPN4 PDZ-PTP. Interestingly, IUpred predicts a dis-
order tendency in the linker (residues 621 to 633) (Fig. 2c). Thus, in agreement with NMR results, bioinformatics 
predictors are consistent with an overall disordered conformation of the linker.
Protection of the linker from limited proteolysis and dynamic behaviour. To complement our results, we char-
acterized PTPN4 PDZ-PTP by limited proteolysis with trypsin, chymotrypsin, and the non-specific subtilisin 
and papain proteases. Indeed, we identified three high specificity chymotrypsin cleavage sites and two trypsin 
cleavage sites in the linker from sequence analysis (Fig. 3a). The PDZ-PTP construct was subjected to limited pro-
teolysis with different protein/protease ratio (100, 1000 and 10000) and different incubation times (0, 10, 60 min 
and overnight after addition of the protease) and at two different temperatures (18 °C and 37 °C). The limited 
Figure 1. Schematic representation of the PTPN4 constructs. Numbers on both extremities of each schematic 
construct correspond to the boundary residues of the construct; Numbers in italic above the schematic 
construct of full-length PTPN4 correspond to the boundary residues of each protein domain.
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proteolysis with a ratio 100 for chymotrypsin and trypsin and a ratio 1000 for subtilisin and papain after 60 min 
at 37 °C shown in Fig. 3b is representative of pattern also obtained with the other limited proteolysis conditions. 
The bands corresponding to the major proteolysis products were identified by mass spectrometry. Surprisingly, 
chymotrypsin, trypsin and subtilisin cleave only in the PDZ or PTP domains, while the linker is only cleaved by 
the non-specific papain in its C-terminal part. The observation that the linker is rather resistant to the proteolysis, 
suggests that the accessibility of this region is sufficiently low to protect it from the hydrolysis of peptide bonds. 
The linker-PTP construct is also rather resistant to the proteolysis (data not shown).
We previously collected dynamical parameters in solution of the bidomain PDZ-PTPC/S (inactive enzyme by 
mutation of the catalytic cysteine) and of the PDZ-linker constructs both in the absence of PBM (unliganded) 
and with a PBM bound (liganded) to the PDZ domain. We reported that the transverse relaxation R2 and the 
longitudinal relaxation R1 values showed that the PDZ domain in the PDZ-PTP construct reorients more freely 
in solution when liganded with dynamic characteristics of the isolated PDZ domain13. We also collected dynam-
ical parameters of the linker. R2 values are shown in Fig. 3c. The linker is flexible in the fast timescale (ps - ns) 
in both constructs. Interestingly, the linker (R2 of 6.5 s−1) is more flexible in the liganded bidomain PDZ-PTPC/S 
than in the unliganded bidomain form (R2 of 13.0 s−1), with R2 values that tend toward the values observed in 
the PBM-liganded PDZ-linker isolated domain (R2 of 5.1 s−1). However, the linker flexibility in the liganded 
PDZ-PTP construct does not reach that of the isolated domain. Although we did not identify a stable surface of 
interaction between PDZ and PTP domains by NMR, from this dynamic behavior, we conclude that the transient 
intramolecular interactions that restrain the PDZ and the linker mobility in unliganded PDZ-PTP are destabi-
lized in the PBM-liganded PDZ-PTP.
Figure 2. Secondary structure and unstructured region predictions of PTPN4 bidomain. (a) Linker sequence 
between the PDZ and PTP domains of PTPN4 (residues 605–637). Secondary structure predictions are shown 
below the sequence. For the different softwares used: h is the prediction of α-helix, e of β-strand and c to 
unstructured (http://npsa-pbil.ibcp.fr). (b) Secondary structure prediction of PDZ-linker construct of PTPN4 
using Talos-N. Probability for the target residue to adopt secondary structure type α-helix or β-strand are 
shown in blue and red, respectively. (c) Unstructured region prediction of PDZ-PTP bidomain construct of 
PTPN4 using IUPred. Inter-domain linker (residues 605–635 of the linker) is indicated. Unstructured regions of 
the linker are shown in black on the sequence. Disorder tendency is shown below with the residue position.
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Sequence alignment-based mutagenesis. To define a potential region of the linker involved in the 
PTPN4 regulation, the sequence of the linker of PTPN4 was aligned with orthologous sequences using the 
InterEvolAlign tool (http://biodev.cea.fr/interevol)19 that allows us to broaden the selection to homologous 
sequences and avoid paralogous sequences. We used a more divergent alignment with all proteins that have a 
PDZ-linker-PTP organization (Fig. 4).
We noticed two conserved stretches of hydrophobic residues in the linker. One, -NAVY-, is located at the 
N-terminus of the linker (residues 604–607) in the region predicted helical by secondary structure predic-
tions programs (Fig. 4). We observed that in a sequence from lice (XP_002422670.1, Pediculus humanus) 
which presents the shortest linker (only 21 residues vs 35 residues in humans), this stretch becomes very short 
(two residues) (Fig. 4). Most interestingly, a more conserved and apolar motif – FQYI – is found in the central 
Figure 3. Limited proteolysis and dynamic behaviour of the linker. (a) Sequence of the linker of PTPN4 with 
the potential sites of cleavage of chymotrypsin and trypsin indicated by C and T, respectively. (b) Gel SDS-PAGE 
after one-hour incubation at 37 °C of PDZ-PTPWT with proteases at a ratio (w:w) of 1:1000 for papain:PDZ-
PTPWT and subtilisin:PDZ-PTPWT, and 1:100 for trypsin:PDZ-PTPWT and chymotrypsin:PDZ-PTPWT. Black 
lines indicate the grouping of the same gel. The most intense bands whose N-terminal sequences were identified 
by mass spectrometry are numbered. Identification of N-terminal sequences of the proteolytic fragments and 
cleavage localizations on PTPN4 are reported in the table. (c) Transverse 15N relaxation rates (R2) of the linker 
within several constructs of PTPN4: unliganded PDZ-linker (green), unliganded PDZ-PTPC/S (black), PBM-
liganded PDZ-linker (blue) and PBM-liganded PDZ-PTPC/S (red). The PBM peptide used is Cyto8-RETEV.
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unstructured part of the linker (residues 620–623) (Fig. 4). We presumed that these highly conserved residues 
could be involved in the regulation of PTPN4 activity by interfacing with the PTP domain. We separately mutated 
the four positions by producing four site-directed glycine variants, namely F620G, Q621G, Y622G and I623G, 
which were analysed by stopped-flow kinetics. We also produced and analysed the mutant ΔFQYI with the dele-
tion of the entire motif FQYI.
Mutations in the inter-domain linker affect the phosphatase kinetics. In order to test the effect 
of sequence composition in the linker on the communication between the PDZ and PTP domains of PTPN4, 
we compared the steady-state kinetics of the bidomain wild-type PDZ-PTP construct (PDZ-PTPWT) to that of 
the F620G, Q621G, Y622G and I623G and ΔFQYI variants. First, we ensured that we obtained similar kcat and 
KM values for the linker-PTP that includes the inter-domain linker and the phosphatase domain, and the PTP 
construct that contains only the PTP domain (Fig. 1)(Table 1). This result indicates that the linker by itself had 
no effect on the PTP domain. Then, the linker-PTP construct was used both as the positive control for maximum 
activity and as the negative control for the regulation by the PDZ domain since no effect of PBM binding was 
observed on the kcat and KM values of the linker-PTP construct as previously reported for the kcat13 (Table 1).
The enzymatic activity was assessed by following the hydrolysis of the widely used phosphatase substrate 
p-nitrophenyl phosphate (pNPP).
Mutants of the linker without PBM peptides are functional with differential defects in catalytic inhibition. Kinetics 
experiments of PTPN4 bidomain constructs were first performed in the absence of PBM corresponding to the 
inhibited state of the phosphatase to determine catalytic parameters of the PTPN4 mutants. We showed that 
Figure 4. Sequence alignment of linker of PTPN4 from different species. The most conserved apolar motifs –
NAVY– and – FQYI– are indicated in a red box.
PTPN4 constructs KM μM kcat s−1 kcat/KM s−1.M−1
PTP 840 ± 60* 5.9 ± 0.2* 7000 ± 550*
linker-PTP 840 ± 130* 5.6 ± 0.5* 6700 ± 1200*
PDZ-PTPWT 230 ± 60 2.0 ± 0.3 8700 ± 1400
PDZ-PTPF620G 400 ± 100 1.3 ± 0.2 3300 ± 1000
PDZ-PTPQ621G 400 ± 100 1.8 ± 0.2 4500 ± 1500
PDZ-PTPY622G 210 ± 40 1.0 ± 0.3 4800 ± 700
PDZ-PTPI623G 210 ± 40 1.5 ± 0.2 7100 ± 1000
PDZ-PTPΔFQYI 70 ± 20 1.8 ± 0.4 25700 ± 10500
Linker-PTP + Cyto8-RETEV 780 ± 100* 6.0 ± 0.4* 7700 ± 1100*
PDZ-PTPWT + Cyto8-RETEV 450 ± 70 2.9 ± 0.3 6500 ± 800
PDZ-PTPF620G + Cyto8-RETEV 350 ± 90 2.0 ± 0.5 5700 ± 1800
PDZ-PTPQ621G + Cyto8-RETEV 320 ± 60 2.5 ± 0.4 7800 ± 1400
PDZ-PTPY622G + Cyto8-RETEV 410 ± 80 1.5 ± 0.3 3500 ± 950
PDZ-PTPI623G + Cyto8-RETEV 330 ± 70 1.9 ± 0.4 5800 ± 1400
PDZ-PTPΔFQYI + Cyto8-RETEV 290 ± 80 3.7 ± 0.9 12800 ± 4700
Table 1. Kinetic parameters of the hydrolysis of pNPP by PTPN4 constructs. The experimental errors are 
derived from a bootstrap analysis except those with an asterisk that come from three independent experiments 
as described previously13.
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PDZ-PTP mutants dephosphorylate the pNPP substrate following Michaelis-Menten kinetics as previously 
reported for the PDZ-PTPWT and linker-PTP (Fig. 5a). In all cases, we observed a clear substrate inhibition effect 
and, therefore, we employed a corrected Michaelis-Menten equation taking into account this effect. The Michaelis 
constant (KM) and the turnover number (kcat) values obtained by fitting the experimental data are listed in Table 1. 
The kcat and KM values decrease when comparing linker-PTP with PDZ-PTPWT as previously reported13. KM val-
ues of Y622G and I623G mutants are similar to the one of the PDZ-PTPWT while those of F620G and Q621G are 
significantly higher by 1.7 fold, with intermediate values between those of PDZ-PTPWT and linker-PTP (Table 1). 
All kcat values are lower than PDZ-PTPWT except for Q621G, which has a value similar to the wild-type. Y622G is 
strongly affected with a kcat value divided by a factor 2 whereas F620G and I623G kcat values decreased by 1.5 and 
1.3 fold, respectively. Hence, it appears that, despite the fact that all the mutations are not involved directly in the 
function of the phosphatase domain, we could observe in all cases a significant effect in either the affinity of PTP 
substrate and/or the catalytic activity of the enzyme. Interestingly, the mutant ΔFQYI is strongly affected in the 
PTP-subtrate affinity with a KM value of 70 μM, divided by a factor 3.3 compared to the PDZ-PTPWT whereas the 
kcat value is similar to the PDZ-PTPWT. The catalysis efficiency (kcat/KM ratio) of ΔFQYI is thus strongly increased.
Figure 5. Phosphatase activity of PTPN4 bidomain constructs mutated in the linker. (a) Michaelis-Menten 
plots of initial rates of pNPP hydrolysis by different PTPN4 proteins at 600 nM without PDZ ligand; (b) 
Michaelis-Menten plots of initial rates of pNPP hydrolysis by different PTPN4 proteins at 600 nM in the 
presence of a saturated concentration of PDZ ligand (70–100 μM of Cyto8-RETEV);  linker-PTP;  PDZ-
PTPWT;  F620G;  Q621G;  Y622G;  I623G. The solid lines are nonlinear least-squares fits of the data 
to the Michaelis-Menten equation. (c) kcat of PTPN4 constructs in the absence of PDZ ligand (light grey) and in 
the presence of PDZ ligand (Cyto8-RETEV) (dark grey). (d) KM of PTPN4 constructs in the absence of PDZ 
ligand (light grey) and in the presence of PDZ ligand (Cyto8-RETEV) (dark grey).
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Mutations of the linker disturb PBM-mediated abrogation of catalytic inhibition. Kinetic experiments of PTPN4 
PDZ-PTP constructs with increasing concentrations of PTPN4-optimized PBM Cyto8-RETEV12 peptide were 
performed to determine catalytic parameters of the bidomain mutants in their “activated” state (Fig. 5b).
Both kcat and KM values of PDZ-PTPWT significantly increase, by a factor of 1.5 and 2, respectively, upon addi-
tion of PBM Cyto8-RETEV whereas the kcat and KM of the linker-PTP are unaffected13 (Table 1)(Fig. 5c). All kcat 
values of PBM-liganded mutants are higher than those of non-liganded mutants (1.3 to 1.5 fold higher depending 
on single mutants) indicating that PBM abrogates inhibition for all mutants, but those values are lower than that of 
PBM-liganded PDZ-PTPWT except for the PBM-liganded ΔFQYI mutant that presents a kcat 2 fold higher. Thus, 
all mutants are affected in the PBM-mediated release of inhibition (Fig. 5c). However, all PDZ-PTP mutants bind 
Cyto8-RETEV with the same affinity as previously reported for PDZ-PTPWT (Kd between 1 and 5 μM deduced from 
the fit of Vm as a function of Cyto8-RETEV concentration). Interestingly, KM of F620G and Q621G are unchanged 
upon the addition of Cyto8-RETEV whereas KM of Y622G and I623G increase (1.9 and 1.5 fold, respectively) as 
observed with the KM of the wild-type (Fig. 5d). As previously observed for the PDZ-PTPWT, both the kcat and KM 
values significantly increase in the presence of Cyto8-RETEV for Y622G and I623G, showing that the release of the 
inhibition operates with a partial compensation of the effect on the two rate constants (Table 1) providing catalysis 
efficiencies (kcat/KM ratios) that are not strongly changed in the presence or absence of the effector peptide.
Hence, all PDZ-PTP mutants are affected in the PBM-mediated regulation of PTPN4 activity either in the modula-
tion of the affinity for the PTP substrate or in the catalytic activity of the enzyme. This modulation of the PDZ-mediated 
inhibition and PBM-mediated release of inhibition of the PTPN4 bidomain suggests that the linker has a function in 
the inter-domain PDZ-PTP communication driving the regulation of the activity of the phosphatase PTPN4.
Discussion
Previous structural investigation of PTPN4 revealed that this enzyme is regulated by a mechanism of 
auto-inhibition which is, at least in part, mediated by an intramolecular communication between the PDZ and 
PTP domains13. Remarkably, the linker region connecting the PDZ and PTP domains is required for such a 
crosstalk, as the regulation is abolished when the two domains are not covalently linked. However, the 33-residue 
linker is flexible and unstructured, and no detectable interaction could be observed by NMR with either the PDZ 
or the PTP domains. These findings prompted us to perform additional investigations, in order to characterize 
more directly the role of the linker in the regulation of PTPN4.
It is interesting to observe that, whilst the linker is largely disordered13, it is not fully solvent accessible, dis-
playing resistance to proteolysis in both PDZ-PTP and linker-PTP constructs and that NMR dynamics parame-
ters (R1 and R2) do not reach the values of the truncated PDZ-linker construct. This suggest a potential interaction 
between the linker and the PTP domain. We previously proposed that the transient intramolecular interactions 
which constrain the PDZ and the linker mobility in unliganded PTPN4 are destabilized in the presence of the 
PBM. Based on multiple sequence alignment, we identified a conserved hydrophobic region in the linker that may 
be involved in the regulation of PTPN4, being universally conserved in PTPN4 from different species.
We showed that mutations in this hydrophobic patch –FQYI–, highly conserved among the PTPN4 ort-
hologous sequences, affects the phosphatase kinetics with effects on kcat and/or KM. Both the inhibition of the 
phosphatase activity by the PDZ domain and the abrogation of the inhibition by the PBM binding are affected, 
indicating that the PDZ-PBM regulation of PTPN4 is a linker-mediated mechanism.
We reported that the PDZ domain inhibits the adjacent catalytic PTP domain through a mixed inhibition 
mechanism, affecting the KM and kcat of the enzyme with opposite effects. The PBM binding to the PDZ domain 
abolishes this auto-inhibition and restores the catalytic properties of PTPN4, most probably affecting the active 
site via a distal interaction occurring through a protein interface. So, the PDZ domain of PTPN4 is not only 
directly involved in discriminating its PBM-containing targets but also allosterically regulates the enzymatic 
activity of the phosphatase through the PDZ-PTP linker. Thus, both the linker sequence and PDZ domain are 
required for the regulation of the enzymatic activity of PTPN4 (Fig. 6). Interestingly, such dynamic inter-domain 
regulation has been observed for the peptidyl-prolyl cis-trans isomerase Pin1. Substrate binding to Pin1 WW 
domain changes the intra/inter domain mobility, thereby altering substrate activity in the distal peptidyl-prolyl 
isomérase catalytic site with evidence of dynamic allostery20.
We propose that the linker participate together with the PDZ domain to the allosteric control of the catalytic 
activity by modulating the kinetic properties of the conserved WPD loop motif closure. Indeed, substrate binding 
is accompanied by a rotation of the WPD loop from an open to a closed position around the phosphotyrosine res-
idue of the substrate that provides residues that are essential for the catalytic cycle21. Moreover, an allosteric regu-
lation of the WPD loop closure was recently detailed in PTP1B showing a modulation of the activity with a likely 
enhancement of the phosphate release step in the PTP1B catalytic cycle22. This type of modulation of the WPD 
loop is consistent with the kinetic parameters of PTPN4. Indeed, a lower KM for the unliganded PDZ-PTPWT is 
related to the open state offering a larger accessibility of the substrate to the catalytic site, while the higher KM and 
kcat for the liganded PDZ-PTPWT is related to the PBM binding that would promote both an enhancement of the 
activity and a decrease in substrate accessibility by triggering the closure of the WPD loop. The F620G and Q621G 
mutants completely lose the regulation on the KM upon PBM binding in agreement with this proposal. Altogether, 
our data strongly suggest a pathway through the linker for the mechanism of PDZ-based regulation of PDZ-PTP 
bidomain with transient inter-domain interactions partially destabilized upon PBM binding.
Methods
Site-directed mutagenesis and protein purification. The variants of PTPN4 named F620G, Q621G, 
Y52G, I623G and ΔFQYI were obtained by using the Quik-Change Mutagenesis kit (Stratagene) according to 
the manufacturer’s instructions, and the substitutions were confirmed by DNA sequencing. Template DNA used 
for PTPN4 mutants was the PDZ-PTPWT construct cloned in a pET15b expression plasmid. The PTP construct 
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was obtained by using the Pwo polymerase (Roche) according to the manufacturer’s instructions, and the inser-
tion was confirmed by DNA sequencing. Template DNA used for the PTP construct was a synthetic construct 
comprising the PTP domain cloned in a pgex6p1 expression plasmid. Expression and purification of linker-PTP 
and PTP construct were performed as described previously13. Bidomain PDZ-PTP variants were expressed and 
purified as previously described without TEV cleavage. Briefly, clarified supernatants were loaded on Ni2+ col-
umn (HiTrap Chelating HP, GE), washed and eluted with an imidazole gradient from 40 mM to 1 M. The eluted 
fractions containing the protein were pooled and loaded on a gel filtration column (Hiload Superdex 75 pg, GE). 
Proteins were concentrated using centrifugal filter devices (Vivaspin, Sartorius). Protein concentration was esti-
mated from its absorbance at 280 nm. The peptide Cyto8-RETEV (SAESHKSGRETEV) was synthesized in solid 
phase using a Fmoc strategy (JPT).
Limited proteolysis. Limited proteolysis was carried out in 50 mM Tris pH 7.5, 150 mM NaCl and 0.5 mM 
TCEP (Tris(2-carboxyethyl)phosphine hydrochloride) using a ratio (w:w) of 1:1000 for papain:PDZ-PTPWT 
and subtilisin:PDZ-PTPWT, and 1:100 for trypsin:PDZ-PTPWT and chymotrypsin:PDZ-PTPWT at 37 °C for 0, 10, 
60 min and overnight. Reaction mixtures at each time interval were stopped by mixing with SDS loading buffer 
and heating at 95 °C for 5 min. Protein fragments were resolved by SDS-PAGE through a 12% polyacrylamide 
gel and visualized by Coomassie staining. The bands corresponding of the major proteolysis products were then 
identified by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS).
Sequence alignment. Sequence of PTPN4 (accession number NP_002821.1) was used as query on the 
InterEvolAlign server19 to retrieve one single homolog per species assessed as probable ortholog through a recip-
rocal blast search procedure against the non-redundant database. Retrieved full-length sequences were re-aligned 
using MAFFT23 and displayed using Jalview24.
Enzymatic assays. Kinetics experiments were carried out on a single-mixing SX-18 stopped-flow instru-
ment (Applied Photophysics). Absorbances values were measured continuously at 410 nm at 25 °C. Experiments 
were performed by mixing a constant concentration of each of the PTPN4 variants, 0.6 μM in the presence of 
increasing concentrations of Cyto8-RETEV peptide, ranging between 0 μM and 100 μM versus increasing con-
centrations of pNPP ranging from 19 μM to 10 mM. The buffer was 50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 
150 mM NaCl, 0.5 mM TCEP. Initial linear reaction rates were calculated during a 20 s reaction. The KM and kcat 
constants were deduced from fitting the Michaelis–Menten equation with the prism software. The equation takes 
into account excess substrate inhibition.
References
 1. Hendriks, W. J. A. J. et al. Protein tyrosine phosphatases in health and disease. FEBS J. 280, 708–730 (2013).
 2. Kina, S. et al. Involvement of protein-tyrosine phosphatase PTPMEG in motor learning and cerebellar long-term depression. Eur. J. 
Neurosci. 26, 2269–2278 (2007).
 3. Kohda, K. et al. The δ2 glutamate receptor gates long-term depression by coordinating interactions between two AMPA receptor 
phosphorylation sites. Proc. Natl. Acad. Sci. USA 110, E948–957 (2013).
 4. Young, J. A. et al. The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs 
and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. Mol. Immunol. 45, 3756–3766 
(2008).
 5. Gu, M., Meng, K. & Majerus, P. W. The effect of overexpression of the protein tyrosine phosphatase PTPMEG on cell growth and on 
colony formation in soft agar in COS-7 cells. Proc. Natl. Acad. Sci. USA 93, 12980–12985 (1996).
 6. Zhou, J. et al. PTPN4 negatively regulates CrkI in human cell lines. Cell. Mol. Biol. Lett. 18, 297–314 (2013).
 7. Huai, W. et al. Phosphatase PTPN4 preferentially inhibits TRIF-dependent TLR4 pathway by dephosphorylating TRAM. J. Immunol. 
Baltim. Md 194, 4458–4465 (2015). 1950.
 8. Gjörloff-Wingren, A. et al. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur. J. Immunol. 30, 
2412–2421 (2000).
 9. Gu, M. & Majerus, P. W. The properties of the protein tyrosine phosphatase PTPMEG. J. Biol. Chem. 271, 27751–27759 (1996).
 10. Préhaud, C. et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci. Signal. 3, ra5 
(2010).
 11. Maisonneuve, P. et al. Molecular Basis of The Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) 
with the Mitogen-Activated Protein Kinase p38γ. J. Biol. Chem.. doi:10.1074/jbc.M115.707208 (2016).
 12. Babault, N. et al. Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death. Struct. Lond. Engl. 
1993(19), 1518–1524 (2011).
Figure 6. Schematic representation of the catalytic regulation of PTPN4. Transient interactions between linker, 
PDZ and PTP domains allosterically inhibit the catalytic activity of PTPN4. The binding of PDZ ligand partially 
disrupts these interactions and consequently activates the phosphatase.
www.nature.com/scientificreports/
9SCIentIFIC REpoRTs | 7: 7875  | DOI:10.1038/s41598-017-08193-6
 13. Maisonneuve, P. et al. Regulation of the catalytic activity of the human phosphatase PTPN4 by its PDZ domain. FEBS J. 281, 
4852–4865 (2014).
 14. King, R. D. & Sternberg, M. J. Identification and application of the concepts important for accurate and reliable protein secondary 
structure prediction. Protein Sci. Publ. Protein Soc. 5, 2298–2310 (1996).
 15. Guermeur, Y., Geourjon, C., Gallinari, P. & Deléage, G. Improved performance in protein secondary structure prediction by 
inhomogeneous score combination. Bioinforma. Oxf. Engl. 15, 413–421 (1999).
 16. Rost, B., Sander, C. & Schneider, R. PHD–an automatic mail server for protein secondary structure prediction. Comput. Appl. Biosci. 
CABIOS 10, 53–60 (1994).
 17. Shen, Y. & Bax, A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural 
networks. J. Biomol. NMR 56, 227–241 (2013).
 18. Dosztányi, Z., Csizmok, V., Tompa, P. & Simon, I. IUPred: web server for the prediction of intrinsically unstructured regions of 
proteins based on estimated energy content. Bioinforma. Oxf. Engl. 21, 3433–3434 (2005).
 19. Faure, G., Andreani, J. & Guerois, R. InterEvol database: exploring the structure and evolution of protein complex interfaces. Nucleic 
Acids Res. 40, D847–856 (2012).
 20. Peng, J. W. Investigating Dynamic Interdomain Allostery in Pin1. Biophys. Rev. 7, 239–249 (2015).
 21. Tonks, N. K. Protein tyrosine phosphatases–from housekeeping enzymes to master regulators of signal transduction. FEBS J. 280, 
346–378 (2013).
 22. Choy, M. S. et al. Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. 
Mol. Cell 65, 644–658 (2017) e5.
 23. Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. 
Mol. Biol. Evol. 30, 772–780 (2013).
 24. Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview Version 2–a multiple sequence alignment 
editor and analysis workbench. Bioinforma. Oxf. Engl. 25, 1189–1191 (2009).
Acknowledgements
We thank Pascal Lenormand (Structural Mass Spectrometry and Proteomics Unit) for its technical expertise. PM 
was supported by grants from the Ministère de l’Enseignement Supérieur et de la Recherche and the Fondation 
pour la Recherche Médicale [FDT20130927999]. KS was a recipient of Erasmus + grant. Work was partly 
supported by grants from the Italian Ministero dell’Istruzione dell’Università e della Ricerca (Progetto di Interesse 
‘Invecchiamento’ to S.G.) and Sapienza University of Rome (C26A155S48 and B52F16003410005 to S.G) and the 
international division of Institut Pasteur.
Author Contributions
C.C.S., P.M., S.G., and N.W. planned the experiments. C.C.S., A.T., E.S., P.M., R.G., K.S. performed the 
experiments. C.C.S., P.M., S.G., R.G. and N.W. analyzed the data. C.C.S., S.G. and N.W. wrote the manuscript. 
C.C.S., P.M., R.G. prepared figures. All authors reviewed the manuscript.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
